The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Preclinical Imaging Solution Market Research Report 2024

Global Preclinical Imaging Solution Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1747247

No of Pages : 101

Synopsis
Preclinical imaging solutions refer to a range of imaging techniques and systems specifically designed for non-invasive imaging and analysis of animals in preclinical research studies. These imaging solutions are used to visualize, study, and quantify biological processes and diseases in small laboratory animals, such as mice and rats, prior to human clinical trials. They play a crucial role in various fields, including pharmaceutical development, biomedical research, and drug discovery.
Global Preclinical Imaging Solution market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Preclinical Imaging Solution market research.
Key companies engaged in the Preclinical Imaging Solution industry include Bruker, PerkinElmer, MILabs, MR Solutions, Aspect Imaging, Mediso, Fujifilm, Siemens Healthineers and TriFoil Imaging, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Preclinical Imaging Solution were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Preclinical Imaging Solution market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Preclinical Imaging Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bruker
PerkinElmer
MILabs
MR Solutions
Aspect Imaging
Mediso
Fujifilm
Siemens Healthineers
TriFoil Imaging
Miltenyi Biotec
LI-COR Biosciences
Biospace Lab
Inviscan
Charles River
Minerva Imaging
Segment by Type
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Positron Emission Tomography (PET)
Single-Photon Emission Computed Tomography (SPECT)
Others
Segment by Application
Hospital
Diagnostic Center
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Preclinical Imaging Solution report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical Imaging Solution Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Magnetic Resonance Imaging (MRI)
1.2.3 Computed Tomography (CT)
1.2.4 Positron Emission Tomography (PET)
1.2.5 Single-Photon Emission Computed Tomography (SPECT)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Preclinical Imaging Solution Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Laboratory
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical Imaging Solution Market Perspective (2018-2029)
2.2 Preclinical Imaging Solution Growth Trends by Region
2.2.1 Global Preclinical Imaging Solution Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Preclinical Imaging Solution Historic Market Size by Region (2018-2023)
2.2.3 Preclinical Imaging Solution Forecasted Market Size by Region (2024-2029)
2.3 Preclinical Imaging Solution Market Dynamics
2.3.1 Preclinical Imaging Solution Industry Trends
2.3.2 Preclinical Imaging Solution Market Drivers
2.3.3 Preclinical Imaging Solution Market Challenges
2.3.4 Preclinical Imaging Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical Imaging Solution Players by Revenue
3.1.1 Global Top Preclinical Imaging Solution Players by Revenue (2018-2023)
3.1.2 Global Preclinical Imaging Solution Revenue Market Share by Players (2018-2023)
3.2 Global Preclinical Imaging Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preclinical Imaging Solution Revenue
3.4 Global Preclinical Imaging Solution Market Concentration Ratio
3.4.1 Global Preclinical Imaging Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical Imaging Solution Revenue in 2022
3.5 Preclinical Imaging Solution Key Players Head office and Area Served
3.6 Key Players Preclinical Imaging Solution Product Solution and Service
3.7 Date of Enter into Preclinical Imaging Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical Imaging Solution Breakdown Data by Type
4.1 Global Preclinical Imaging Solution Historic Market Size by Type (2018-2023)
4.2 Global Preclinical Imaging Solution Forecasted Market Size by Type (2024-2029)
5 Preclinical Imaging Solution Breakdown Data by Application
5.1 Global Preclinical Imaging Solution Historic Market Size by Application (2018-2023)
5.2 Global Preclinical Imaging Solution Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Preclinical Imaging Solution Market Size (2018-2029)
6.2 North America Preclinical Imaging Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Preclinical Imaging Solution Market Size by Country (2018-2023)
6.4 North America Preclinical Imaging Solution Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preclinical Imaging Solution Market Size (2018-2029)
7.2 Europe Preclinical Imaging Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Preclinical Imaging Solution Market Size by Country (2018-2023)
7.4 Europe Preclinical Imaging Solution Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preclinical Imaging Solution Market Size (2018-2029)
8.2 Asia-Pacific Preclinical Imaging Solution Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Preclinical Imaging Solution Market Size by Region (2018-2023)
8.4 Asia-Pacific Preclinical Imaging Solution Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preclinical Imaging Solution Market Size (2018-2029)
9.2 Latin America Preclinical Imaging Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Preclinical Imaging Solution Market Size by Country (2018-2023)
9.4 Latin America Preclinical Imaging Solution Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical Imaging Solution Market Size (2018-2029)
10.2 Middle East & Africa Preclinical Imaging Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Preclinical Imaging Solution Market Size by Country (2018-2023)
10.4 Middle East & Africa Preclinical Imaging Solution Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bruker
11.1.1 Bruker Company Detail
11.1.2 Bruker Business Overview
11.1.3 Bruker Preclinical Imaging Solution Introduction
11.1.4 Bruker Revenue in Preclinical Imaging Solution Business (2018-2023)
11.1.5 Bruker Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Detail
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Preclinical Imaging Solution Introduction
11.2.4 PerkinElmer Revenue in Preclinical Imaging Solution Business (2018-2023)
11.2.5 PerkinElmer Recent Development
11.3 MILabs
11.3.1 MILabs Company Detail
11.3.2 MILabs Business Overview
11.3.3 MILabs Preclinical Imaging Solution Introduction
11.3.4 MILabs Revenue in Preclinical Imaging Solution Business (2018-2023)
11.3.5 MILabs Recent Development
11.4 MR Solutions
11.4.1 MR Solutions Company Detail
11.4.2 MR Solutions Business Overview
11.4.3 MR Solutions Preclinical Imaging Solution Introduction
11.4.4 MR Solutions Revenue in Preclinical Imaging Solution Business (2018-2023)
11.4.5 MR Solutions Recent Development
11.5 Aspect Imaging
11.5.1 Aspect Imaging Company Detail
11.5.2 Aspect Imaging Business Overview
11.5.3 Aspect Imaging Preclinical Imaging Solution Introduction
11.5.4 Aspect Imaging Revenue in Preclinical Imaging Solution Business (2018-2023)
11.5.5 Aspect Imaging Recent Development
11.6 Mediso
11.6.1 Mediso Company Detail
11.6.2 Mediso Business Overview
11.6.3 Mediso Preclinical Imaging Solution Introduction
11.6.4 Mediso Revenue in Preclinical Imaging Solution Business (2018-2023)
11.6.5 Mediso Recent Development
11.7 Fujifilm
11.7.1 Fujifilm Company Detail
11.7.2 Fujifilm Business Overview
11.7.3 Fujifilm Preclinical Imaging Solution Introduction
11.7.4 Fujifilm Revenue in Preclinical Imaging Solution Business (2018-2023)
11.7.5 Fujifilm Recent Development
11.8 Siemens Healthineers
11.8.1 Siemens Healthineers Company Detail
11.8.2 Siemens Healthineers Business Overview
11.8.3 Siemens Healthineers Preclinical Imaging Solution Introduction
11.8.4 Siemens Healthineers Revenue in Preclinical Imaging Solution Business (2018-2023)
11.8.5 Siemens Healthineers Recent Development
11.9 TriFoil Imaging
11.9.1 TriFoil Imaging Company Detail
11.9.2 TriFoil Imaging Business Overview
11.9.3 TriFoil Imaging Preclinical Imaging Solution Introduction
11.9.4 TriFoil Imaging Revenue in Preclinical Imaging Solution Business (2018-2023)
11.9.5 TriFoil Imaging Recent Development
11.10 Miltenyi Biotec
11.10.1 Miltenyi Biotec Company Detail
11.10.2 Miltenyi Biotec Business Overview
11.10.3 Miltenyi Biotec Preclinical Imaging Solution Introduction
11.10.4 Miltenyi Biotec Revenue in Preclinical Imaging Solution Business (2018-2023)
11.10.5 Miltenyi Biotec Recent Development
11.11 LI-COR Biosciences
11.11.1 LI-COR Biosciences Company Detail
11.11.2 LI-COR Biosciences Business Overview
11.11.3 LI-COR Biosciences Preclinical Imaging Solution Introduction
11.11.4 LI-COR Biosciences Revenue in Preclinical Imaging Solution Business (2018-2023)
11.11.5 LI-COR Biosciences Recent Development
11.12 Biospace Lab
11.12.1 Biospace Lab Company Detail
11.12.2 Biospace Lab Business Overview
11.12.3 Biospace Lab Preclinical Imaging Solution Introduction
11.12.4 Biospace Lab Revenue in Preclinical Imaging Solution Business (2018-2023)
11.12.5 Biospace Lab Recent Development
11.13 Inviscan
11.13.1 Inviscan Company Detail
11.13.2 Inviscan Business Overview
11.13.3 Inviscan Preclinical Imaging Solution Introduction
11.13.4 Inviscan Revenue in Preclinical Imaging Solution Business (2018-2023)
11.13.5 Inviscan Recent Development
11.14 Charles River
11.14.1 Charles River Company Detail
11.14.2 Charles River Business Overview
11.14.3 Charles River Preclinical Imaging Solution Introduction
11.14.4 Charles River Revenue in Preclinical Imaging Solution Business (2018-2023)
11.14.5 Charles River Recent Development
11.15 Minerva Imaging
11.15.1 Minerva Imaging Company Detail
11.15.2 Minerva Imaging Business Overview
11.15.3 Minerva Imaging Preclinical Imaging Solution Introduction
11.15.4 Minerva Imaging Revenue in Preclinical Imaging Solution Business (2018-2023)
11.15.5 Minerva Imaging Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’